Neurofilament Light Chain: Method Validation of Quantitation Using the Quanterix Simoa™ Platform and Potential Applications

In this study, we quantify Neurofilament Light Chain (NF-L) in human plasma, serum, and CSF on the Quanterix Simoa™ Platform using a commercial Simoa NF-Light Assay Kit provided by Quanterix Corporation. We also discuss potential applications.

"*" indicates required fields

First Name*

Last Name*

Company*

State*

Country

Email*

Phone*

Please only hit the submit button once.

I AGREE*

By submitting this form I agree that Frontage may process my data in the manner described in Frontage’s Privacy Policy.

Comments

This field is for validation purposes and should be left unchanged.

Neurofilament Light Chain: Method Validation of Quantitation Using the Quanterix Simoa™ Platform and Potential Applications

Resources to Consider

Method Validation of Quantitation IL-17A in Human Serum using the...

Analysis of Semi-and Non-Volatile Leachables via an Enhanced HPLC-UV...

Development and validation of an LC-MS/MS method for the...

Testing of Carryover & After MRD Benchtop Stability for...

Bioanalytical Methods for Emerging Therapies

Development and Validation of an LC-MS.MS Method for the Simultaneous...

An Ultrasensitive LC-APPI-MS/MS Method for Simultaneous...

Overcoming Stability Issues in the Development of an LC-MS/MS...

Development And Validation Of LC-MS/MS Methods For The…

Development and Validation of an Ultra Sensitive LC-MS/MS Method for...

Validation of a Low-Volume Plasma LC-MS/MS Method Using a...

Biomarker and Alzheimer’s disease: role of high sensitivity...